1926sek
-0,1 %
Date:2024-12-20Time:17:29:00Latest report:Q3-2024List:Small CapTicker:ORX
Market Cap:635 msekEnterprise Value:1 000 msekNet Sales:595,8 msekEarnings:-105,3 msekEmployees:0ISIN:SE0000736415

Ratios

10-year key figure history for Orexo turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Orexo with index and moving average MA50 and MA200.

Stockprice:19,26
MA50:13,14
MA200:16,22
Price/MA200:12,8 %
RSI (14):64,8
Price/MA50:39,2 %

Description

Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo’s groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo’s headquarters in Uppsala, Sweden.

Pharmaceuticals